Overview
The purpose of this study is to evaluate the pharmacokinetics, safety, and tolerability of NSHO-101 in Healthy Participants.
Eligibility
Inclusion Criteria:
- Participants (males and females) at least 18 years of age
- Ability to provide written informed consent
- In good heath as determined by medical evaluation,
- Willing and able to comply with trial restrictions, procedures, and requirements
Exclusion Criteria:
- Known sensitivity to any components of the IMP
- History of relevant drug hypersensitivity
- Presents or has a history of clinically significant diseases
- History of difficulty swallowing tablets or capsules.
- Any physical examination findings or medical history that might place the participant at an unacceptable risk for participation in this trial.